These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26125949)

  • 1. The Role of Immunohistochemistry in Rhabdomyosarcoma Diagnosis Using Tissue Microarray Technology and a Xenograft Model.
    Machado I; Mayordomo-Aranda E; Giner F; Llombart-Bosch A
    Fetal Pediatr Pathol; 2015; 34(5):271-81. PubMed ID: 26125949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics.
    Grass B; Wachtel M; Behnke S; Leuschner I; Niggli FK; Schäfer BW
    Histopathology; 2009 Jun; 54(7):873-9. PubMed ID: 19469909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.
    Morotti RA; Nicol KK; Parham DM; Teot LA; Moore J; Hayes J; Meyer W; Qualman SJ;
    Am J Surg Pathol; 2006 Aug; 30(8):962-8. PubMed ID: 16861966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma.
    Virgone C; Lalli E; Bisogno G; Lazzari E; Roma J; Zin A; Poli E; Cecchetto G; Dall'Igna P; Alaggio R
    PLoS One; 2015; 10(7):e0133019. PubMed ID: 26168243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.
    Rudzinski ER; Anderson JR; Lyden ER; Bridge JA; Barr FG; Gastier-Foster JM; Bachmeyer K; Skapek SX; Hawkins DS; Teot LA; Parham DM
    Am J Surg Pathol; 2014 May; 38(5):654-9. PubMed ID: 24618610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.
    Kumar S; Perlman E; Harris CA; Raffeld M; Tsokos M
    Mod Pathol; 2000 Sep; 13(9):988-93. PubMed ID: 11007039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.
    Davicioni E; Anderson MJ; Finckenstein FG; Lynch JC; Qualman SJ; Shimada H; Schofield DE; Buckley JD; Meyer WH; Sorensen PH; Triche TJ
    Am J Pathol; 2009 Feb; 174(2):550-64. PubMed ID: 19147825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry.
    Wachtel M; Runge T; Leuschner I; Stegmaier S; Koscielniak E; Treuner J; Odermatt B; Behnke S; Niggli FK; Schäfer BW
    J Clin Oncol; 2006 Feb; 24(5):816-22. PubMed ID: 16391296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma.
    Tuohy JL; Byer BJ; Royer S; Keller C; Nagai-Singer MA; Regan DP; Seguin B
    Vet Pathol; 2021 May; 58(3):516-526. PubMed ID: 33691532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyosarcoma of the breast: a clinicopathologic study and review of the literature.
    Li DL; Zhou RJ; Yang WT; Wang J; Yao XH; Cheng YF; Shi DR
    Chin Med J (Engl); 2012 Jul; 125(14):2618-22. PubMed ID: 22882949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
    Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
    Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of a muscle ankyrin-repeat protein, Arpp, in paraffin-embedded tumors: evaluation of Arpp as a tumor marker for rhabdomyosarcoma.
    Ishiguro N; Motoi T; Osaki M; Araki N; Minamizaki T; Moriyama M; Ito H; Yoshida H
    Hum Pathol; 2005 Jun; 36(6):620-5. PubMed ID: 16021567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors. Expression of cytokeratin and the 68-kD neurofilament protein.
    Miettinen M; Rapola J
    Am J Surg Pathol; 1989 Feb; 13(2):120-32. PubMed ID: 2464953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX7 Expression in Rhabdomyosarcoma, Related Soft Tissue Tumors, and Small Round Blue Cell Neoplasms.
    Charville GW; Varma S; Forgó E; Dumont SN; Zambrano E; Trent JC; Lazar AJ; van de Rijn M
    Am J Surg Pathol; 2016 Oct; 40(10):1305-15. PubMed ID: 27526298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study.
    Zin A; Bertorelle R; Dall'Igna P; Manzitti C; Gambini C; Bisogno G; Rosolen A; Alaggio R
    Am J Surg Pathol; 2014 Feb; 38(2):273-8. PubMed ID: 24418861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyosarcoma in children - current pathologic and molecular classification.
    Dziuba I; Kurzawa P; Dopierała M; Larque AB; Januszkiewicz-Lewandowska D
    Pol J Pathol; 2018; 69(1):20-32. PubMed ID: 29895123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: a Children's Oncology Group study.
    Nicol K; Savell V; Moore J; Teot L; Spunt SL; Qualman S;
    Pediatr Dev Pathol; 2007; 10(2):89-97. PubMed ID: 17378682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rhabdomyosarcomas: structural distribution and analysis of an immunohistochemical profile].
    Botiralieva GK; Sharlai AS; Roshchin VY; Sidorov IV; Konovalov DM
    Arkh Patol; 2020; 82(5):33-41. PubMed ID: 33054030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.